Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Govt exempts exporters from payment of various fees, charges
The government today exempted exporters from paying fees for availing incentives under various export development schemes and reduced other charges.

Lupin buys worldwide rights for nasal spray AllerNaze
Pharma firm Lupin today said it has acquired the worldwide rights for nasal spray AllerNaze from Collegium Pharmaceutical for an undisclosed amount.

News of the day

Abhishek Ind plans JV with Portuguese co
The Trident Group company Abhishek Industries today said it is planning to enter into a joint venture with the Portugal-based Mundotextil Industrias to produce luxury linen and other home textile products.
Management

Sun Pharma, Forest settle US suit on Lexapro

Sun Pharmaceutical Industries and its subsidiary, Caraco Pharmaceutical Laboratories, have reached a settlement agreement with drugmaker Forest Laboratories and licensing partner H Lundbeck AS, over a pending patent infringement dispute over Forest’s blockbuster antidepressant, Lexapro. - Sun Pharma gets USFDA nod for generic anti-cancer drug - Sun extends Taro open offer to April 17">Sun extends Taro open offer to April 17 - Sun Pharma announces US nod for Topamax tablets - Sun, Taro chiefs meet for out-of-court settlement Caraco had filed an application with the US Food and Drug Administration (USFDA) to launch a cheaper version of Lexapro, but Forest and H Lundbeck AS moved to block the drug, alleging it infringed the company’s patents. Under the agreement announced by the companies, Forest will give Caraco patents to Lexapro, when other generic versions of the drug become available. Caraco will also take over sales of certain Forest products.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009